Clofarabine a lifeline in relapsed and refractory paediatric leukaemia

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1473, 2005-01, pp. : 13-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clofarabine in paediatric patients with acute lymphoblastic leukaemia: profile report

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 4, 2006-04 ,pp. : 3-5

Adis International

Access to resources Recommend Favorite

Imatinib: In Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia

By Cross Sarah A.   Lyseng-Williamson Katherine A.  

Drugs, Vol. 67, Iss. 17, 2007-01 ,pp. : 2645-2654

Adis International

Access to resources Recommend Favorite

Imatinib in Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia: A Viewpoint by Joseph Brandwein

By Brandwein Joseph  

Drugs, Vol. 67, Iss. 17, 2007-01 ,pp. : 2655-2656

Adis International

Access to resources Recommend Favorite

The novel sulfonylhydrazine alkylating agent VNP 40101M may be a feasible treatment for patients with relapsed or refractory leukaemia

By  

Inpharma, Vol. 1, Iss. 1441, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a review

By Kline Justin P   Larson Richard A  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 15, 2005-12 ,pp. : 2711-2718

Informa Healthcare

Access to resources Recommend Favorite